# Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy

> **NCT03249727** · NA · TERMINATED · sponsor: **ATGen Canada Inc** · enrollment: 396 (actual)

## Conditions studied

- Immunity, Innate
- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** IVDD for NK cell activity in whole blood

## Key facts

- **NCT ID:** NCT03249727
- **Lead sponsor:** ATGen Canada Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-05
- **Primary completion:** 2018-10-11
- **Final completion:** 2018-10-11
- **Target enrollment:** 396 (ACTUAL)
- **Why stopped:** Recruiting issues
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249727, "Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03249727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*